Komori
Financial results presentation6574Convano Inc.Information and Communications, Services and Others

Full-Year Earnings Presentation for the Fiscal Year Ending March 2026

In the fiscal year ended March 2026, revenue and profit increased substantially, primarily due to the expansion of the Consulting and Healthcare businesses. From the fiscal year ending March 2027 onward, the company shifted to a conservative plan that excludes BTC-related income and unfinalized M&A, and presented growth targets centered on AI and recurring-revenue businesses.

Worth reading
47Recurring
Scored from 5 of 6 sections
Direction
Improvement
Direction inferred from the company’s description.
Scale
6507
¥ million (year-on-year change in Non-GAAP operating profit)
Wording
Conditional
How definitive the wording is.

Contents of this document

Financial results presentationFiscal year ending March 2026, full year6 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥15,500 million+378.3%
Operating profit¥6,642 million Non-GAAP
Gross Profit Margin48.8%
Operating profit margin42.9%（Non-GAAP）
Selling, general and administrative expenses¥1,802 million
Full-year earnings forecast
Fiscal year ending March 2027
Revenue
¥26,752 million
Operating profit
¥8,957 million
By segment
Nail
Revenue
¥3,961 million
Operating profit
¥381 million
Consulting
Revenue
¥18,023 million
Operating profit
¥6,308 million
Healthcare
Revenue
¥4,000 million
Operating profit
¥2,000 million
AI
Revenue
¥768 million
Operating profit
¥268 million
Investment & Advisory
Revenue
¥0 million
Operating profit
¥0 million
What the company explained in this material
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
  • BTC-related income
    AssumptionsAssumes zero for all gains and losses from holdings, valuation and sales
  • M&A income
    AssumptionsAssumes zero except for finalized transactions
  • Consulting revenue
    AssumptionsBuilt up based on the continuation of existing contracts and a low churn rate
  • Healthcare revenue
    AssumptionsConservatively factors in expected sales to a 500-institution network
  • Nail business revenue
    AssumptionsBased on stable revenue from the existing 73 locations, with limited new openings factored in
New initiatives
  • SaaS rollout of axon, the company-developed AI business automation platform
  • Rollout of 5 AI products
  • M&A strategy aimed at strengthening the beauty medical and healthcare businesses, as well as AI systems and data infrastructure
  • Business partnership with CM Plus and joint development with CellBank
  • Target of 100 nail salons nationwide and No. 1 market share in the nail business
Key KPIsA metric the company considers important as a management benchmark.
  • Healthcare Institution NetworkMore than 500
  • Number of nail salons73 Location
  • Annual database of the AI recruitment platformMore than 20,000
  • Customer base130,000 per month
  • Target reduction in work hours for AI-based ordering of medical supplies80 %
Segment results
Nail
Revenue
¥3,264 million
Year-on-year change in revenue+17.1%
Profit
¥102 million
Year-on-year change in profitReturn to profitability
Consulting
Revenue
¥8,332 million
Year-on-year change in revenue+2844.2%
Profit
¥2,918 million
Year-on-year change in profit+1922.5%
Healthcare
Revenue
¥2,339 million
Year-on-year change in revenue+2239.0%
Profit
¥1,555 million
Year-on-year change in profit+2229.4%
Investment & Advisory
Revenue
¥1,565 million
Year-on-year change in revenue+2745.5%
Profit
¥2,015 million excluding the loss on period-end fair value measurement of crypto assets
Year-on-year change in profit+4112.2%
Medium-term management plan targets
Fiscal year ending March 2028
Revenue
¥30,010 million
Operating profit
¥10,372 million
Operating profit margin34.6%
Fiscal year ending March 2029
Revenue
¥37,090 million
Operating profit
¥13,053 million
Operating profit margin35.2%
Number of stores and locations
End of period73 Location
Contents of this document
ItemDetails
Document typeFinancial results presentation
Fiscal Period CoveredFiscal year ending March 2026, full year
Net Sales¥15,500 million (YoY +378.3%)
Operating profit¥6,642 million (Non-GAAP)
Gross Profit Margin48.8%
Operating profit margin42.9%（Non-GAAP）
Selling, general and administrative expenses¥1,802 million
Full-year earnings forecastFiscal year ending March 2027 Revenue ¥26,752 million / Operating profit ¥8,957 million / By segment Nail Revenue ¥3,961 million / Operating profit ¥381 million / Consulting Revenue ¥18,023 million / Operating profit ¥6,308 million / Healthcare Revenue ¥4,000 million / Operating profit ¥2,000 million / AI Revenue ¥768 million / Operating profit ¥268 million / Investment & Advisory Revenue ¥0 million / Operating profit ¥0 million
Segment resultsNail Revenue ¥3,264 million / Year-on-year change in revenue +17.1% / Profit ¥102 million / Year-on-year change in profit Return to profitability / Consulting Revenue ¥8,332 million / Year-on-year change in revenue +2844.2% / Profit ¥2,918 million / Year-on-year change in profit +1922.5% / Healthcare Revenue ¥2,339 million / Year-on-year change in revenue +2239.0% / Profit ¥1,555 million / Year-on-year change in profit +2229.4% / Investment & Advisory Revenue ¥1,565 million / Year-on-year change in revenue +2745.5% / Profit ¥2,015 million (excluding the loss on period-end fair value measurement of crypto assets) / Year-on-year change in profit +4112.2%
Key KPIsIndicator name Healthcare Institution Network / Value More than 500 / Year on year against the same period last year Not disclosed, Indicator name Number of nail salons / Value 73 Location / Year on year against the same period last year Not disclosed, Indicator name Annual database of the AI recruitment platform / Value More than 20,000 / Year on year against the same period last year Not disclosed, Indicator name Customer base / Value 130,000 per month / Year on year against the same period last year Not disclosed, Indicator name Target reduction in work hours for AI-based ordering of medical supplies / Value 80 % / Year on year against the same period last year Not disclosed
Number of stores and locationsEnd of period 73 Location / Number of store openings and closures during the period Not disclosed
Assumptions Underlying the Business OutlookItem BTC-related income / Assumptions Assumes zero for all gains and losses from holdings, valuation and sales, Item M&A income / Assumptions Assumes zero except for finalized transactions, Item Consulting revenue / Assumptions Built up based on the continuation of existing contracts and a low churn rate, Item Healthcare revenue / Assumptions Conservatively factors in expected sales to a 500-institution network, Item Nail business revenue / Assumptions Based on stable revenue from the existing 73 locations, with limited new openings factored in
Medium-term management plan targetsFiscal year ending March 2028 Revenue ¥30,010 million / Operating profit ¥10,372 million / Operating profit margin 34.6% / Fiscal year ending March 2029 Revenue ¥37,090 million / Operating profit ¥13,053 million / Operating profit margin 35.2%
New initiativesSaaS rollout of axon, the company-developed AI business automation platform, Rollout of 5 AI products, M&A strategy aimed at strengthening the beauty medical and healthcare businesses, as well as AI systems and data infrastructure, Business partnership with CM Plus and joint development with CellBank, Target of 100 nail salons nationwide and No. 1 market share in the nail business
Items this document does not state (17)
Ordinary incomeNet incomeResults for the three months of the current quarterProgress against full-year forecastSelf-assessment against the planBreakdown of Factors Affecting the ChangeUnit price and quantity metricsNumber of employeesRisk amount incorporated into the outlookFinancial targetsAnnual DividendPayout ratioAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue and profitability improved as the Consulting and Healthcare businesses grew, management resources were concentrated on both businesses, and highly recurring revenue expanded.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Full-Year Earnings Presentation for the Fiscal Year Ending March 2026 | Convano Inc. (6574) timely disclosure | Komori